NCT07418463

Brief Summary

Electroconvulsive therapy (ECT) is an effective treatment for severe depression and other psychiatric disorders. ECT is usually given in several sessions on different days. During each session, patients receive short-acting anesthesia to ensure comfort and safety. This study aims to evaluate whether the amount of anesthetic medication required changes during repeated ECT sessions in the same patient. In addition, the study will examine the relationship between anesthetic dose, seizure duration, seizure quality (measured by postictal suppression index), and recovery time. This is a prospective observational study. All anesthesia and ECT procedures will be performed according to routine clinical practice. No additional intervention will be applied for research purposes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 18, 2026

Completed
25 days until next milestone

Study Start

First participant enrolled

March 15, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 13, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 13, 2026

Completed
Last Updated

June 16, 2026

Status Verified

June 1, 2026

Enrollment Period

3 months

First QC Date

February 11, 2026

Last Update Submit

June 13, 2026

Conditions

Keywords

Electroconvulsive TherapyAnesthesia

Outcome Measures

Primary Outcomes (1)

  • Change in Anesthetic Dose Requirement Across Repeated ECT Sessions

    Dose (mg) of the anesthetic agent administered for each ECT session (e.g., propofol or etomidate), recorded from anesthesia records and analyzed as within-subject change across sequential sessions.

    Across the first 4 ECT sessions per participant (from Session 1 to Session 4), during the study period (up to 3 months).

Study Arms (1)

Adults Undergoing Repeated ECT

Adult patients aged 18-65 years with an indication for electroconvulsive therapy (ECT) who are scheduled to undergo multiple ECT sessions under routine clinical practice. All anesthesia and ECT procedures will be performed according to standard institutional protocols. No additional intervention will be applied for research purposes. Repeated within-subject measurements will be collected across ECT sessions.

Procedure: Electroconvulsive Therapy (ECT)

Interventions

Electroconvulsive therapy administered as part of routine clinical care. The study does not assign or modify the intervention. Anesthetic management and ECT parameters are determined by treating physicians according to standard institutional protocols.

Adults Undergoing Repeated ECT

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients aged 18-65 years with an established indication for electroconvulsive therapy (ECT) who are scheduled to undergo multiple ECT sessions at a tertiary care hospital. Participants will be consecutively enrolled during the study period according to eligibility criteria. All procedures will be performed as part of routine clinical care.

You may qualify if:

  • Age 18 to 65 years.
  • Scheduled to undergo electroconvulsive therapy (ECT) under elective conditions as part of routine clinical care.
  • ECT indication (e.g., major depressive disorder, bipolar depression, schizoaffective disorder, catatonia).
  • ASA Physical Status I-III.
  • Planned to receive multiple ECT sessions.
  • Able to provide written informed consent (participant and/or legally authorized representative).

You may not qualify if:

  • Use of antiepileptic drugs or benzodiazepines that may affect seizure threshold.
  • ECT received within the past 6 months.
  • Severe cardiovascular, pulmonary, or neurologic comorbidity (investigator judgment).
  • Pregnancy or breastfeeding.
  • ASA Physical Status IV or higher.
  • Acute substance or alcohol use disorder/intoxication.
  • Conditions preventing EEG monitoring (e.g., scalp trauma, significant skin lesions, cranial implants).
  • Inability to obtain reliable BIS monitoring during anesthesia induction due to technical limitations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir City Hospital

Izmir, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Electroconvulsive Therapy

Intervention Hierarchy (Ancestors)

Convulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiology and Reanimation Specialist, MD

Study Record Dates

First Submitted

February 11, 2026

First Posted

February 18, 2026

Study Start

March 15, 2026

Primary Completion

June 13, 2026

Study Completion

June 13, 2026

Last Updated

June 16, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations